DRY EYE TREATMENT
Tixel i® for Evaporative Dry Eye
A two-minute, in-office treatment for adults with dry eye caused by meibomian gland dysfunction.
Tixel i® is FDA-cleared to apply localized heat and pressure therapy to the eyelids of adults with evaporative dry eye disease due to meibomian gland dysfunction (MGD).
Treatment of both eyes takes approximately two minutes. Your individual treatment plan and results will depend on your examination.
SEE THE TREATMENT
How Tixel i works
Tixel delivers very brief pulses of controlled heat with gentle pressure to the outer eyelids. The goal is to treat meibomian gland dysfunction and support a more stable tear film.
UNDERSTANDING YOUR SYMPTOMS
Could blocked eyelid glands be contributing to your dry eye?
Common symptoms
- Itching or stinging
- Redness
- Light sensitivity
- Eye fatigue
- Blurry or fluctuating vision
- Watery or tearing eyes
What is MGD?
The meibomian glands in your eyelids produce oils that slow tear evaporation. When these glands become blocked or do not function normally, the tear film can evaporate too quickly, causing evaporative dry eye.
Not every case of dry eye is caused by MGD. A complete evaluation helps determine what is contributing to your symptoms and which treatment is appropriate.
YOUR TREATMENT PLAN
What to expect
Before treatment
Your clinician will review your symptoms, examine your tear film and eyelid glands, cleanse the treatment area, and use appropriate eye protection. Topical numbing gel may be used.
During treatment
The handpiece is applied gently to the upper and lower eyelids. You may feel brief warmth and pressure. Treatment of both eyes takes approximately two minutes.
After treatment
Temporary watering or blurry vision can occur immediately afterward. Most patients can return to normal activities without planned downtime.
Typical treatment schedule
Our usual treatment course is three sessions spaced approximately two weeks apart. Your doctor may recommend a different plan based on your examination and response to treatment.
EVIDENCE AND SAFETY
Clear expectations, without overpromising.
In the FDA-reviewed pivotal trial, patients treated with Tixel showed improvement in tear breakup time, dry-eye symptoms, and meibomian gland scores through three months. Tixel was non-inferior to LipiFlow for tear breakup time at one month.
No device- or procedure-related adverse events were reported in that trial. Individual experiences and results vary.
FREQUENTLY ASKED QUESTIONS
Questions about Tixel i
Does treatment hurt?
Patients generally feel brief warmth and gentle pressure. No injections or general anesthesia are required; topical numbing gel may be used.
Is there downtime?
Planned downtime is generally not required. Temporary watering or blurry vision may occur immediately after treatment.
How many treatments will I need?
Many patients receive three treatments approximately two weeks apart, but recommendations may vary.
How quickly will I notice improvement?
Timing and degree of improvement vary. Your doctor will monitor your symptoms and clinical findings throughout treatment.
Is Tixel i appropriate for your dry eye?
Schedule an evaluation to identify the cause of your symptoms and discuss treatment options.